ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 26040 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 26040; 2) Community: the network communities that were significantly associated with the response to NSC 26040; 3) Molecule: the relationships between components within communities and NSC 26040; 4) MDR: the compounds that were significantly associated with the NSC 26040.

NSC Compound Enrichment Correlation
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.027843564133142 0.16624112
NSC 668366 Null 0.027843564133142 0.1991042
NSC 671119 Null 0.027843564133142 0.3802961
NSC 671963 Null 0.027843564133142 0.22136991
NSC 673188 - 0.027843564133142 0.19572541
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.027843564133142 0.27434792
NSC 678989 Uracil, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-, cis- 0.027843564133142 0.19081887
NSC 683252 Null 0.027843564133142 0.012389814
NSC 683332 Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer 0.027843564133142 0.075094296
NSC 686573 Null 0.027843564133142 0.270172
Total:64  Current:38    [First] [Prev] [Next] [Last]